Cost of Exempting Sole Orphan Drugs From Medicare Negotiation is a research paper published in JAMA Internal Medicine (2024). On theSindex it has a DataRank of 0.421. It has been cited 11 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.0485
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
NHLBI NIH HHS
Grant: K08 HL163246
MeSH Terms